InsidersTradesSigma
Track the 华纳药厂 stock price and the full insider trade history of the company, a listed equity based in China. Shares are quoted on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 华纳药厂 has recorded 2 public disclosures. Market capitalisation: €5.6bn. The latest transaction was disclosed on 15 December 2022 (Sale). Among the most active insiders: 金焰. All data is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
华纳药厂 是一家在健康和制药领域的公司，在XSHG市场上市。它专注于创新药物的研发。